Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...
News Medical on MSN
Pioneering technology enables scalable production of human kidney organoids
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research ...
LOS ANGELES — Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other ...
People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by ...
Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...
DUBLIN--(BUSINESS WIRE)--The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. This ...
CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...
Scientists at City of Hope have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 diabetes (T2D) by converting pancreatic cells that normally produce insulin into ...
Approximately 9.5 million people globally live with Type 1 diabetes, a chronic autoimmune disease where T cells from the body’s immune system destroy insulin-producing cells in the pancreas, which are ...
Plus, get the best of BroadwayWorld delivered to your inbox, and unlimited access to our editorial content across the globe. Theatre Producers of Color announced the return of their annual educational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback